EC
CNTA

EcoR1 Capital’s Centessa Pharmaceuticals CNTA Stock Holding History

EcoR1 Capital’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238M Buy
6,000,000
+2,885,000
+93% +$73.8M 10.11% 4
2025
Q4 		$77.9M Buy
3,115,000
+2,565,000
+466% +$65M 3.53% 5
2025
Q3 		$13.3M Buy
+550,000
New +$9.78M 0.64% 22
2024
Q4 		– Sell
-3,223,851
Closed -$51.5M – 63
2024
Q3 		$51.5M Sell
3,223,851
-2,490,553
-44% -$30.5M 1.76% 15
2024
Q2 		$51.6M Buy
5,714,404
+95,625
+2% +$907K 1.58% 17
2024
Q1 		$63.5M Hold
5,618,779
– – 1.61% 20
2023
Q4 		$44.7M Hold
5,618,779
– – 1.16% 17
2023
Q3 		$36.4M Hold
5,618,779
– – 1.23% 16
2023
Q2 		$34.8M Hold
5,618,779
– – 0.85% 19
2023
Q1 		$21.6M Buy
5,618,779
+386,500
+7% +$1.41M 0.7% 24
2022
Q4 		$16.2M Buy
5,232,279
+1,995,927
+62% +$7.4M 0.49% 32
2022
Q3 		$13M Buy
3,236,352
+2,944,032
+1,007% +$13.5M 0.38% 35
2022
Q2 		$1.42M Sell
292,320
-162,225
-36% -$1.04M 0.05% 67
2022
Q1 		$4.08M Sell
454,545
-427,631
-48% -$3.9M 0.13% 55
2021
Q4 		$9.93M Buy
882,176
+127,631
+17% +$1.72M 0.32% 37
2021
Q3 		$12.6M Hold
754,545
– – 0.44% 30
2021
Q2 		$16.8M Buy
+754,545
New +$17.7M 0.63% 30

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

EcoR1 Capital's CNTA Position: Q1 2026 in Review

EcoR1 Capital increased its Centessa Pharmaceuticals (CNTA) stake by 93% in Q1 2026, buying an estimated $73.8M and bringing the position to 6,000,000 shares worth $238M. The position accounts for 10.11% of the portfolio, ranked #4.

EcoR1 Capital first reported a position in CNTA in Q2 2021 and has held it in 17 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • EcoR1 Capital held 6,000,000 shares of Centessa Pharmaceuticals worth $238M as of Q1 2026.
  • EcoR1 Capital bought 2,885,000 Centessa Pharmaceuticals shares in Q1 2026, an estimated $73.8M.
  • Centessa Pharmaceuticals made up 10.11% of EcoR1 Capital's portfolio in Q1 2026, its #4 holding.
  • EcoR1 Capital first reported a position in Centessa Pharmaceuticals in Q2 2021 and has held it in 17 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on EcoR1 Capital's 13F filing for Q1 2026, filed 15 May 2026.